ID: ALA2071631

Max Phase: Preclinical

Molecular Formula: C11H14BrNO2

Molecular Weight: 272.14

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(OC(=O)N(C)C)c(Br)c1C

Standard InChI:  InChI=1S/C11H14BrNO2/c1-7-5-6-9(10(12)8(7)2)15-11(14)13(3)4/h5-6H,1-4H3

Standard InChI Key:  QNLVLMZLSNKLMO-UHFFFAOYSA-N

Associated Targets(Human)

Neutral cholesterol ester hydrolase 1 158 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 272.14Molecular Weight (Monoisotopic): 271.0208AlogP: 3.13#Rotatable Bonds: 1
Polar Surface Area: 29.54Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.49CX LogD: 3.49
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.79Np Likeness Score: -0.75

References

1. Shreder KR, Lin EC, Wu J, Cajica J, Amantea CM, Hu Y, Okerberg E, Brown HE, Pham LM, Chung de M, Fraser AS, McGee E, Rosenblum JS, Kozarich JW..  (2012)  Synthesis and structure-activity relationship of (1-halo-2-naphthyl) carbamate-based inhibitors of KIAA1363 (NCEH1/AADACL1).,  22  (17): [PMID:22877630] [10.1016/j.bmcl.2012.05.102]

Source